Showing 1 - 10 of 7,826
Persistent link: https://www.econbiz.de/10011817398
Persistent link: https://www.econbiz.de/10003729378
A non-trivial fraction of people cannot afford to buy pharmaceutical products at unregulated market prices. This paper analyses the public insurance of a patent-protected pharmaceutical product in terms of price controls and socially optimal third-degree price discrimination. First, the paper...
Persistent link: https://www.econbiz.de/10013286496
A non-trivial fraction of people cannot afford to buy pharmaceutical products at unregulated market prices. Therefore, the paper analyzes the public insurance of the pharmaceutical products in terms of price controls and the socially optimal third-degree price discrimination. It characterizes...
Persistent link: https://www.econbiz.de/10012157261
in reducing pharmaceuticals prices. Results are not as strong for demand side measures. Profit controls and the use of …
Persistent link: https://www.econbiz.de/10009503923
Persistent link: https://www.econbiz.de/10000824795
Persistent link: https://www.econbiz.de/10003346480
Persistent link: https://www.econbiz.de/10003866168
Persistent link: https://www.econbiz.de/10003410519
Persistent link: https://www.econbiz.de/10003381812